[Therapy of chronic cardiac insufficiency with cardiac glycosides].
D002301:Cardiac Glycosides / Q000378:metabolism / Q000627:therapeutic use*; D004074:Digitoxin / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D006207:Half-Life; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007668:Kidney / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D011442:Proscillaridin / Q000627:therapeutic use; D013328:Strophanthins / Q000627:therapeutic use
D002301:Cardiac Glycosides; D013328:Strophanthins; D004077:Digoxin; D004074:Digitoxin; D011442:Proscillaridin
Therapie der chronischen Herzinsuffizienz mit Herzglykosiden.